GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Price-to-Free-Cash-Flow

Sphere Medical Holding (LSE:SPHR) Price-to-Free-Cash-Flow : N/A (As of Jun. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Price-to-Free-Cash-Flow?

As of today (2024-06-12), Sphere Medical Holding's share price is £0.00. Sphere Medical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.05. Hence, Sphere Medical Holding's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Sphere Medical Holding's Price-to-Free-Cash-Flow or its related term are showing as below:

LSE:SPHR's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.79
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Sphere Medical Holding's Free Cash Flow per Share for the six months ended in Dec. 2016 was £-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was £-0.05.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -21.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -29.10% per year.

During the past 9 years, Sphere Medical Holding's highest 3-Year average Free Cash Flow per Share Growth Rate was 5.50% per year. The lowest was -34.10% per year. And the median was -24.45% per year.


Sphere Medical Holding Price-to-Free-Cash-Flow Historical Data

The historical data trend for Sphere Medical Holding's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Price-to-Free-Cash-Flow Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - -

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sphere Medical Holding's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Sphere Medical Holding's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Price-to-Free-Cash-Flow falls into.



Sphere Medical Holding Price-to-Free-Cash-Flow Calculation

Sphere Medical Holding's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.00/-0.048
=N/A

Sphere Medical Holding's Share Price of today is £0.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sphere Medical Holding's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2016 was £-0.05.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Sphere Medical Holding  (LSE:SPHR) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Sphere Medical Holding Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.